The goal of this clinical study is to evaluate a new process for assessing and alleviating chemotherapy-induced peripheral neuropathy in the feet in patients treated with chemotherapy for early stage breast cancer. It will also compare two orthopedic interventions for symptom relief. The main questions it aims to answer are: Can an orthopedic silicone orthosis reduce chemotherapy-induced peripheral neuropathy symptoms in the feet? How does the effectiveness of the silicone orthosis compare to standard orthopedic treatment with insoles and shoes? Participants will: Use either a silicone orthosis or standard orthopedic treatment Have contact with the clinic for assessments and follow-ups Report their symptoms and functional improvements over time
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in foot neuropathy grade after 3-6 weeks of using the silicone orthosis.
Timeframe: At baseline and after three to six weeks after treatment initiation
Change in Change in physical activity level after 3-6 weeks of using the silicone orthosis.
Timeframe: During two weeks after initiation of treatment
Change in foot neuropathy symptoms after 3-6 weeks of using the silicone orthosis.
Timeframe: At baseline and after 3-6 weeks after initiation of treatment.